Search alternatives:
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 mean » 12 men (Expand Search), 2012 mean (Expand Search)
1 nm » 10 nm (Expand Search), 1 mm (Expand Search), 1 m (Expand Search)
nm decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
12 mean » 12 men (Expand Search), 2012 mean (Expand Search)
1 nm » 10 nm (Expand Search), 1 mm (Expand Search), 1 m (Expand Search)
-
1
-
2
-
3
-
4
Dexamethasone decreases PGC-1α protein expression and transcription.
Published 2016“…<p>(A) Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased PGC-1α protein expression (p = 0.01). n = 3/treatment from 3 experiments. …”
-
5
Dexamethasone decreases CRTC1 and CRTC2 nuclear localization.
Published 2016“…<p>Treatment of L6 myotubes with Dex (100nM, 48hrs) decreased (A) total CRTC1 (p = 0.004 and CRTC2 protein (p = 0.0007). n = 9/treatment from 3 experiments. …”
-
6
-
7
-
8
-
9
ANG II treatment leads to decreased contractile function.
Published 2016“…<p>(A,) MTF Chip. (A,i) Photograph of experimental setup (Scale bar: 1 cm). …”
-
10
-
11
-
12
-
13
Characterization of the optimized nanoparticles (These values are means of a minimum of 5 batches).
Published 2015Subjects: -
14
-
15
-
16
-
17
-
18
-
19
Vasopressin decreases EPSPs in CA2 after LTP induction.
Published 2013“…Bottom graph: typical example showing that the amplitude of the EPSP increased transiently (short-term facilitation) after HFS and then progressively to reach a plateau (long-term potentiation: LTP). Vasopressin (AVP 10 nM; 1 min) applied during LTP transiently decreased the EPSP amplitude. …”
-
20